In silico and in vitro evaluation of imatinib as an inhibitor for SARS-CoV-2

References

• (CDC), C. f. D. C. a. P. (2021). Treatments Your Healthcare Provider Might Recommend if You Are Sick. https://www.cdc.gov/coronavirus/2019-ncov/your-health/treatments-for-severe-illness.html
   Google Scholar
• (NIH), N. I. o. H. (2021). What;s New in the Guidelines. https://www.covid19treatmentguidelines.nih.gov/about-the-guidelines/whats-new/
   Google Scholar
• (WHO), W. H. O. (2020). World Health Organization “Solidarity” clinical trial for COVID-19 treatments. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments
   Google Scholar
• Allaire, J. (2012). RStudio: Integrated development environment for R. Boston, MA, 537, 538.
   Google Scholar
• Basha, S. H. (2020). Corona virus drugs – A brief overview of past, present and future. Journal of PeerScientist. Journal of Peer Scientist, 2(2), e1000013.
   Google Scholar
• Bernal-Bello, D., Morales-Ortega, A., Farfán-Sedano, A. I., de Tena, J. G., & San Martín-López, J. V. (2021). Imatinib in COVID-19: Hope and caution. The Lancet. Respiratory Medicine, 9(9), 938–939. https://doi.org/10.1016/S2213-2600(21)00266-6
   PubMed Web of Science ®Google Scholar
• Coleman, C. M., Sisk, J. M., Mingo, R. M., Nelson, E. A., White, J. M., & Frieman, M. B. (2016). Abelson kinase inhibitors are potent inhibitors of severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus fusion. Journal of Virology, 90(19), 8924–8933. https://doi.org/10.1128/JVI.01429-16
   PubMed Web of Science ®Google Scholar
• Cucinotta, D., & Vanelli, M. (2020). WHO declares COVID-19 a pandemic. Acta Bio-Medica: Atenei Parmensis, 91(1), 157–160.
   PubMedGoogle Scholar
• Dong, E., Du, H., & Gardner, L. (2020). An interactive web-based dashboard to track COVID-19 in real time. The Lancet Infectious Diseases, 20(5), 533–534. https://doi.org/10.1016/S1473-3099(20)30120-1
   PubMed Web of Science ®Google Scholar
• Dyall, J., Coleman, C. M., Hart, B. J., Venkataraman, T., Holbrook, M. R., Kindrachuk, J., Johnson, R. F., Olinger, G. G., Jahrling, P. B., Laidlaw, M., Johansen, L. M., Lear-Rooney, C. M., Glass, P. J., Hensley, L. E., & Frieman, M. B. (2014). Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrobial Agents and Chemotherapy, 58(8), 4885–4893.
   PubMed Web of Science ®Google Scholar
• Han, Y., Duan, X., Yang, L., Nilsson-Payant, B. E., Wang, P., Duan, F., Tang, X., Yaron, T. M., Zhang, T., Uhl, S., Bram, Y., Richardson, C., Zhu, J., Zhao, Z., Redmond, D., Houghton, S., Nguyen, D.-H T., Xu, D., Wang, X., … Chen, S. (2021). Identification of SARS-CoV-2 inhibitors using lung and colonic organoids. Nature, 589(7841), 270–275.
   PubMed Web of Science ®Google Scholar
• Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., Müller, M. A., Drosten, C., & Pöhlmann, S. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 181(2), 271–280.e8. https://doi.org/10.1016/j.cell.2020.02.052
   PubMed Web of Science ®Google Scholar
• Hou, T., Wang, J., Li, Y., & Wang, W. (2011). Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. Journal of Chemical Information and Modeling, 51(1), 69–82.
   PubMed Web of Science ®Google Scholar
• Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., Zhang, Q., Shi, X., Wang, Q., & Zhang, L. (2020). Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature, 581(7807), 215–220.
   PubMed Web of Science ®Google Scholar
• Letko, M., Marzi, A., & Munster, V. (2020). Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nature microbiology, 5(4), 562–569.
   Google Scholar
• Li, J. N., Abel, R., Zhu, K., Cao, Y. X., Zhao, S. W., & Friesner, R. A. (2011). The VSGB 2.0 model: A next generation energy model for high resolution protein structure modeling. Proteins, 79(10), 2794–2812. https://doi.org/10.1002/prot.23106
   PubMed Web of Science ®Google Scholar
• Lin, Y.-Z., Shen, Y.-C., Wu, W.-R., Wang, W.-J., Wang, Y.-L., Lin, C.-Y., Hung, M.-C., & Wang, S.-C. (2021). Imatinib (STI571) inhibits the expression of angiotensin-converting enzyme 2 and cell entry of the SARS-CoV-2-derived pseudotyped viral particles. International Journal of Molecular Sciences, 22(13), 6938. https://doi.org/10.3390/ijms22136938
   PubMed Web of Science ®Google Scholar
• Morales-Ortega, A., Rivas-Prado, L., Frutos-Pérez, B., Jaenes-Barrios, B., Farfán-Sedano, A. I., García-Parra, C. J., Hernández-Muniesa, B., Duarte-Millán, M. Á., Madroñal-Cerezo, E., Ontañón-Nasarre, A., Ruiz-Giardín, J. M., Bermejo, F., García-Gil, M., Gonzalo-Pascua, S., San Martín-López, J. V., & Bernal-Bello, D. (2021). Early clinical experience with imatinib in COVID-19: Searching for a dual effect. The Journal of Infection, 82(5), 186–230. https://doi.org/10.1016/j.jinf.2021.02.002
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• O’Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open Babel: An open chemical toolbox. Journal of Cheminformatics, 3, 33. https://doi.org/10.1186/1758-2946-3-33
   PubMed Web of Science ®Google Scholar
• of the International, C. S. G. (2020). The species Severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology, 5(4), 536.
   Web of Science ®Google Scholar
• Okba, N. M. A., Müller, M. A., Li, W., Wang, C., GeurtsvanKessel, C. H., Corman, V. M., Lamers, M. M., Sikkema, R. S., de Bruin, E., Chandler, F. D., Yazdanpanah, Y., Le Hingrat, Q., Descamps, D., Houhou-Fidouh, N., Reusken, C. B. E. M., Bosch, B.-J., Drosten, C., Koopmans, M. P. G., & Haagmans, B. L. (2020). Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease 2019. Emerging Infectious Diseases, 26(7), 1478–1488. https://doi.org/10.3201/eid2607.200841
   PubMed Web of Science ®Google Scholar
• Ortega, J. T., Serrano, M. L., Pujol, F. H., & Rangel, H. R. (2020). Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis. EXCLI Journal, 19, 410–417. https://doi.org/10.17179/excli2020-1167
   PubMed Web of Science ®Google Scholar
• Release, S. (2017a). 1: Maestro. Schrödinger, LLC, New York, NY. 2017.
   Google Scholar
• Release, S. (2017b). 4: Desmond molecular dynamics system. DE Shaw Research, New York, NY.
   Google Scholar
• Roos, K., Wu, C. J., Damm, W., Reboul, M., Stevenson, J. M., Lu, C., Dahlgren, M. K., Mondal, S., Chen, W., Wang, L. L., Abel, R., Friesner, R. A., & Harder, E. D. (2019). OPLS3e: Extending force field coverage for drug-like small molecules. Journal of Chemical Theory and Computation, 15(3), 1863–1874. https://doi.org/10.1021/acs.jctc.8b01026
   PubMed Web of Science ®Google Scholar
• Rossari, F., Minutolo, F., & Orciuolo, E. (2018). Past, present, and future of Bcr-Abl inhibitors: From chemical development to clinical efficacy. Journal of Hematology & Oncology, 11(1), 84. https://doi.org/10.1186/s13045-018-0624-2
   PubMedGoogle Scholar
• Sisk, J. M., Frieman, M. B., & Machamer, C. E. (2018). Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors. The Journal of General Virology, 99(5), 619–630.
   PubMed Web of Science ®Google Scholar
• Srinivasan, J., Cheatham, T. E., Cieplak, P., Kollman, P. A., & Case, D. A. (1998). Continuum solvent studies of the stability of DNA, RNA, and phosphoramidate - DNA helices. Journal of the American Chemical Society, 120(37), 9401–9409. https://doi.org/10.1021/ja981844+
   Web of Science ®Google Scholar
• Sterling, T., & Irwin, J. J. (2015). ZINC 15–ligand discovery for everyone. Journal of chemical information and modeling, 55(11), 2324–2337.
   Google Scholar
• Touret, F., Driouich, J. S., Cochin, M., Petit, P. R., Gilles, M., Barthélémy, K., Moureau, G., Mahon, F. X., Malvy, D., Solas, C., de Lamballerie, X., & Nougairède, A. (2021). Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2. Antiviral Research, 193, 105137. https://doi.org/10.1016/j.antiviral.2021.105137
   PubMed Web of Science ®Google Scholar
• Trott, O., & Olson, A. J. (2010). Software news and update AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/10.1002/jcc.21334
   PubMed Web of Science ®Google Scholar
• Wang, E., Sun, H., Wang, J., Wang, Z., Liu, H., Zhang, J. Z., & Hou, T. (2019). End-point binding free energy calculation with MM/PBSA and MM/GBSA: Strategies and applications in drug design. Chemical Reviews, 119(16), 9478–9508. https://doi.org/10.1021/acs.chemrev.9b00055
   PubMed Web of Science ®Google Scholar
• Warnes, G.R., Bolker, B, Bonebakker, L., Gentleman, R., Liaw, W.H.A., Lumley, T., Maechler, M., Magnusson, A., Moeller, S., Schwartz, M. and Venables, B. (2016). gplots: Various R Programming Tools for Plotting Data. R package version 3.0.1. https://CRAN.Rproject.org/package=gplots
   Google Scholar
• Waterhouse, A., Bertoni, M., Bienert, S., Studer, G., Tauriello, G., Gumienny, R., Heer, F. T., de Beer, T. A. P., Rempfer, C., Bordoli, L., Lepore, R., & Schwede, T. (2018). SWISS-MODEL: Homology modelling of protein structures and complexes. Nucleic Acids Research, 46(W1), W296–W303.
   PubMed Web of Science ®Google Scholar
• Wizard, P. P. (2014). Schrödinger Release 2021-4: Protein Preparation Wizard; Epik, Schrödinger, LLC, New York, NY, 2021; Impact, Schrödinger, LLC, New York, NY; Prime, Schrödinger, LLC, New York, NY, 2021.
   Google Scholar
• World Health Organization (WHO). (2020). WHO| Novel Coronavirus–China. WHO. https://www.who.int/emergencies/disease-outbreak-news/item/2020-DON233
   Google Scholar
• Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020). Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science (New York, N.Y.), 367(6483), 1260–1263. https://doi.org/10.1126/science.abb2507
   PubMed Web of Science ®Google Scholar
• Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Hu, Y., Song, Z.-G., Tao, Z.-W., Tian, J.-H., & Pei, Y.-Y. (2020). A new coronavirus associated with human respiratory disease in China. Nature, 579, 265–269. https://doi.org/10.1038/s41586-020-2008-3
   Google Scholar
• Zhao, H., Mendenhall, M., & Deininger, M. W. (2020). Imatinib is not a potent anti-SARS-CoV-2 drug. Leukemia, 34(11), 3085–3087. https://doi.org/10.1038/s41375-020-01045-9
   PubMed Web of Science ®Google Scholar
• Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., & Huang, C.-L. (2020a). Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. bioRxiv,
   Google Scholar
• Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., Chen, H.-D., Chen, J., Luo, Y., Guo, H., Jiang, R.-D., Liu, M.-Q., Chen, Y., Shen, X.-R., Wang, X., … Shi, Z.-L. (2020b). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270–273. https://doi.org/10.1038/s41586-020-2012-7
   PubMed Web of Science ®Google Scholar
• Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., & Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine, 382(8), 727–733. https://doi.org/10.1056/NEJMoa2001017
   PubMed Web of Science ®Google Scholar
• Zumla, A., Chan, J. F., Azhar, E. I., Hui, D. S., & Yuen, K.-Y. (2016). Coronaviruses—Drug discovery and therapeutic options. Nature Reviews. Drug Discovery, 15(5), 327–347.
   PubMed Web of Science ®Google Scholar